Clinical Trial Update: A Study Assessing Arrhythmia Mapping With the Multi-Electrode OPTRELL™ Mapping Catheter [NA]

View source ↗

Summary

Clinical trial evaluating arrhythmia mapping with the OPTRELL multi-electrode mapping catheter has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation
• Persistent Atrial Fibrillation
• Scar-related Atrial Tachycardia
• Tachycardia Ventricular
• Ventricular Premature Complexes

Drugs mentioned

• OPTRELL mapping catheter (multi-electrode mapping catheter)

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Scar-related Atrial Tachycardia, Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2023-01-19